CANCER 2026 Najah Nassif
University of Technology Sydney, NSW, Australia
Presentations this author is a contributor to:
Repurposing the cardiac glycoside digoxin as a targeted treatment for SMARCA4-mutant ovarian cancer (#147)
5:40 PM
Natisha R Field
Welcome Reception & Poster Session 1